EIX
58
4
NOV
48
-4
TSCO
50
-3
CMA
65
-6
DVA
47
-3
STI
7
2
MDLZ
28
6
VMC
53
3
CAT
66
2
MUR
33
-5
CINF
66
2
CHRW
79
3
JBHT
63
3
COF
67
2
ADSK
62
6
GLW
67
3
PCAR
62
-2
LRCX
71
22
CCL
65
3
AAL
53
2
EIX
58
4
NOV
48
-4
TSCO
50
-3
CMA
65
-6
DVA
47
-3
STI
7
2
MDLZ
28
6
VMC
53
3
CAT
66
2
MUR
33
-5
CINF
66
2
CHRW
79
3
JBHT
63
3
COF
67
2
ADSK
62
6
GLW
67
3
PCAR
62
-2
LRCX
71
22
CCL
65
3
AAL
53
2
Financhill
Back

KraneShares Emerging Markets Consumer Tech Idx ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Buy
58

KEMQ
KraneShares Emerging Markets Consumer Tech Idx ETF

Last Price:
$25.70
Seasonality Move:
0.75%
Sell
27

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.68
Seasonality Move:
-18.07%
Buy
58
KraneShares Emerging Markets Consumer Tech Idx ETF (KEMQ) is a Buy

Is KraneShares Emerging Markets Consumer Tech Idx ETF a Buy, Sell or Hold?

  • The current KraneShares Emerging Markets Consumer Tech Idx ETF [KEMQ] share price is $25.24. The Score for KEMQ is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • KEMQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.53. The Score for INKT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KEMQ Stock Price Chart

What is KraneShares Emerging Markets Consumer Tech Idx ETF's stock price today?

  • The KraneShares Emerging Markets Consumer Tech Idx ETF share price today is $25.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KEMQ is experiencing selling pressure, which indicates risk of future bearish movement.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.

KEMQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 42.24 Sell
Chaikin Money Flow: -3597 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.24 - 26.08) Sell
Bollinger Bands (100): (23.78 - 26.76) Sell

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 44.15 Sell
Chaikin Money Flow: -6795 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.47) Sell
Bollinger Bands (100): (12.26 - 15.22) Sell

KEMQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.49 Sell
20-day SMA: 25.54 Sell
50-day SMA: 26.08 Sell
200-day SMA: 22.75 Buy
8-day EMA: 25.37 Sell
20-day EMA: 25.63 Sell
50-day EMA: 25.34 Sell
200-day EMA: 16.14 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.26 Sell
20-day SMA: 11.59 Sell
50-day SMA: 12.86 Sell
200-day SMA: 11.87 Sell
8-day EMA: 11.94 Sell
20-day EMA: 12 Sell
50-day EMA: 12.64 Sell
200-day EMA: 12.22 Sell

KraneShares Emerging Markets Consumer Tech Idx ETF Earnings Growth & KEMQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

KraneShares Emerging Markets Consumer Tech Idx ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):